4.6 Review

Complex regulation of γ-secretase: from obligatory to modulatory subunits

期刊

FRONTIERS IN AGING NEUROSCIENCE
卷 6, 期 -, 页码 -

出版社

FRONTIERS MEDIA SA
DOI: 10.3389/fnagi.2014.00342

关键词

gamma-Secretase; Alzheimer'sdisease; presenilin; beta-amyloid; Notch; APP; Hif-1 alpha

资金

  1. NIH [R01AG026660, R01NS076117]
  2. Alzheimer Association [IIRG-12-242147]
  3. Met-Life Foundation
  4. JPB Foundation
  5. training grant NIH [T32 CA062948]
  6. Commonwealth Foundation for Cancer Research
  7. Experimental Therapeutics Center of MSKCC
  8. William Randolph Hearst Fund in Experimental Therapeutics

向作者/读者索取更多资源

gamma-Secretase is a four subunit, 19-pass transmembrane enzyme that cleaves amyloid precursor protein (APP), catalyzing the formation of amyloid beta (A beta) peptides that form amyloid plaques, which contribute to Alzheimer's disease (AD) pathogenesis. gamma-Secretase also cleaves Notch, among many other type I transmembrane substrates. Despite its seemingly promiscuous enzymatic capacity, gamma-secretase activity is tightly regulated. This regulation is a function of many cellular entities, including but not limited to the essential gamma-secretase subunits, nonessential (modulatory) subunits, and gamma-secretase substrates. Regulation is also accomplished by an array of cellular events, such as presenilin (active subunit of gamma-secretase) endoproteolysis and hypoxia. In this review we discuss how gamma-secretase is regulated with the hope that an advanced understanding of these mechanisms will aid in the development of effective therapeutics for gamma-secretase-associated diseases like AD and Notch- addicted cancer.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据